| CYSB2500109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2025-05-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2500100 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2025-05-13 | | Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd | | | view |
| CYSB2500061 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500062 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500050 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | Supplementary Application | 2025-03-07 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400323 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-12-13 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400300 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-14 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400288 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-05 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400282 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-10-26 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400219 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-14 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400179 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-09 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400167 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| CYSB2400139 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400073 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-03-18 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2400054 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-02-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400053 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-02-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
